KemPharm, Inc. (KMPH) SEC filings
KMPH SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the KMPH overview →
18 measured KMPH SEC filing events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form DEF 14A ZEVRA THERAPEUTICS, INC. For: May 13 | SEC filing · Form DEF | — | — | |
| Form DEFA14A ZEVRA THERAPEUTICS, INC. | SEC filing · Form DEFA14A | — | — | |
| Form S-8 ZEVRA THERAPEUTICS, INC. | SEC filing · Form S-8 | — | — | |
| Form 10-K ZEVRA THERAPEUTICS, INC. For: Dec 31 | SEC filing · Form 10-K | — | — | |
| Form 8-K ZEVRA THERAPEUTICS, INC. For: Mar 28 | SEC filing · Form 8-K | — | — | |
| Form 8-K ZEVRA THERAPEUTICS, INC. For: Mar 26 | SEC filing · Form 8-K | — | — | |
| Form 8-K ZEVRA THERAPEUTICS, INC. For: Mar 05 | SEC filing · Form 8-K | — | — | |
| Form 8-K ZEVRA THERAPEUTICS, INC. For: Mar 04 | SEC filing · Form 8-K | — | — | |
| Form 8-K ZEVRA THERAPEUTICS, INC. For: Feb 22 | SEC filing · Form 8-K | — | — | |
| Form 8-K/A ZEVRA THERAPEUTICS, INC. For: Nov 20 | SEC filing · Form 8-K | — | — | |
| Form S-3 ZEVRA THERAPEUTICS, INC. | SEC filing · Form S-3 | — | — | |
| Form 8-K ZEVRA THERAPEUTICS, INC. For: Jan 23 | SEC filing · Form 8-K | — | — | |
| Form 8-K ZEVRA THERAPEUTICS, INC. For: Jan 08 | SEC filing · Form 8-K | — | — | |
| Form 8-K ZEVRA THERAPEUTICS, INC. For: Dec 22 | SEC filing · Form 8-K | — | — | |
| Form 8-K ZEVRA THERAPEUTICS, INC. For: Nov 20 | SEC filing · Form 8-K | — | — | |
| Form 10-Q ZEVRA THERAPEUTICS, INC. For: Sep 30 | SEC filing · Form 10-Q | — | — | |
| Form 8-K ZEVRA THERAPEUTICS, INC. For: Nov 07 | SEC filing · Form 8-K | — | — | |
| Form 8-K ZEVRA THERAPEUTICS, INC. For: Oct 30 | SEC filing · Form 8-K | — | — |
Keep exploring
More KMPH: earnings → · analyst actions → · KMPH overview →
Other Healthcare names and their SEC filings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Concert Pharmaceuticals, Inc. (CNCE) | 911 | 0.00% | 48% |
| TROVAGENE (TROV) | 906 | -0.52% | 40% |
| Nektar Therapeutics (NKTR) | 898 | +0.07% | 53% |
| Tandem Diabetes Care, Inc. (TNDM) | 895 | +0.13% | 57% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its SEC filings — that is what the link opens.